0.1(top 100%)
impact factor
208(top 50%)
papers
216(top 50%)
citations
6(top 50%)
h-index
0.1(top 100%)
impact factor
417
all documents
232
doc citations
10(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Empirically Based and DSM-Oriented Assessment of Preschoolers for Pharmacotherapy and Other InterventionsChild and Adolescent Psychopharmacology News200117
2Post-Test and Evaluation for Child & Adolescent Psychopharmacology News 21(5)Child and Adolescent Psychopharmacology News201615
3The Kutcher Adolescent Depression Scale (KADS)Child and Adolescent Psychopharmacology News200413
4Psychotropic Medicines and Aggressive BehaviorChild and Adolescent Psychopharmacology News20028
5Ziprasidone as a Weight-Neutral Alternative in the Treatment of Self-Injurious Behavior in Adolescent FemalesChild and Adolescent Psychopharmacology News20058
6Evidenced-Based Treatment of PTSD in Children and Adolescents: Where Does Psychopharmacology Fit?Child and Adolescent Psychopharmacology News20127
7Advances in the Pharmacotherapy of Pervasive Developmental Disorders (PDD)Child and Adolescent Psychopharmacology News20036
8ADHD By Night: Sleep Problems and ADHD MedicationsChild and Adolescent Psychopharmacology News20076
9Clinical Pharmacology of Conduct Disorder: A Critical ReviewChild and Adolescent Psychopharmacology News20116
10Treatment of Children and Adolescents with Posttraumatic Stress Disorder (PTSD): A Review of Current EvidenceChild and Adolescent Psychopharmacology News20126
11Deprescribing and Its Application to Child PsychiatryChild and Adolescent Psychopharmacology News20166
12Ethical and Legal Problems in Treating Schizophrenic Patients with Neuroleptics During Childhood and AdolescenceChild and Adolescent Psychopharmacology News20035
13The Role of Behavioral Analysis in the Pharmacotherapy of Emotionally Dysregulated Problem BehaviorsChild and Adolescent Psychopharmacology News20055
14Adolescent Self-Mutilatory Behavior: Psychopharmacological TreatmentChild and Adolescent Psychopharmacology News20034
15Psychotropic Medicines and Aggressive Behavior Part II: Antipsychotics and Mood StabilizersChild and Adolescent Psychopharmacology News20034
16Adult Attention Deficit Hyperactivity DisorderChild and Adolescent Psychopharmacology News20044
17Treatment of Preschool ADHD: Overview of the Preschool ADHD Treatment Study (PATS)Child and Adolescent Psychopharmacology News20074
18Prescriptions Into Practice: Aripiprazole (Abilify): A Novel Atypical Antipsychotic MedicationChild and Adolescent Psychopharmacology News20084
19Review of Proposed Changes in Child and Adolescent Psychiatry Diagnostic Criteria for DSM-Version 5Child and Adolescent Psychopharmacology News20104
20Psychotropic Medications and Their Effect on Brain Volumes in Childhood PsychopathologyChild and Adolescent Psychopharmacology News20144
21Adolescent Substance Use Disorders: Principles for Assessment and ManagementChild and Adolescent Psychopharmacology News20154
22Polypharmacy and the Pursuit of Appropriate Prescribing for Children and AdolescentsChild and Adolescent Psychopharmacology News20174
23Internet Resources: Substance Abuse and Mental Health Services Administration (SAMHSA)Child and Adolescent Psychopharmacology News20033
24Pharmacological Treatment Options for Panic Disorder in Children and AdolescentsChild and Adolescent Psychopharmacology News20073
25Prescriptions Into Practice: Bupropion—A Guide to Rational Clinical UseChild and Adolescent Psychopharmacology News20083
26Effects of Stimulants and SSRIs on Brain Function in Children: Emerging Clues from fMRI studiesChild and Adolescent Psychopharmacology News20113
27Pediatric Obsessive-Compulsive Disorder: A Psychopharmacology UpdateChild and Adolescent Psychopharmacology News20163
28Topiramate in the Management of Bipolar DisorderChild and Adolescent Psychopharmacology News20012
29Identification and Treatment of Malignant CatatoniaChild and Adolescent Psychopharmacology News20032
30Drug-Induced QT Interval Prolongation and Torsade De Pointes in Children and Adolescents—Part I of a Four Part SeriesChild and Adolescent Psychopharmacology News20032
31Use of Venlafaxine in Child and Adolescent PsychiatryChild and Adolescent Psychopharmacology News20032
32Lamotrigine In Adolescent Treatment–Resistant DepressionChild and Adolescent Psychopharmacology News20062
33Medicating Children: The Enduring Controversy over ADHD and Pediatric Stimulant PharmacotherapyChild and Adolescent Psychopharmacology News20082
34Focus: The Use of Psychotropic Drugs in Autism and Other Pervasive Developmental DisordersChild and Adolescent Psychopharmacology News20092
35Are Children With Severe Outbursts Diagnostically Homeless?Child and Adolescent Psychopharmacology News20092
36The Use of Psychotropic Agents in Preschool Children: Issues in Practice, Research and Public PolicyChild and Adolescent Psychopharmacology News20092
37The Pharmacotherapy of Adolescent Opioid DependenceChild and Adolescent Psychopharmacology News20102
38Medication Adherence: What Adolescents are Saying and What Prescribers Can DoChild and Adolescent Psychopharmacology News20102
39Non-Pharmacological Treatment of Problem Behaviors in Children with Autism Spectrum DisorderChild and Adolescent Psychopharmacology News20112
40Pharmacotherapy of Anxiety and Repetitive Behaviors in Autism Spectrum DisordersChild and Adolescent Psychopharmacology News20142
41Predicting Treatment Response in Pediatric Anxiety DisordersChild and Adolescent Psychopharmacology News20142
42Childhood Onset SchizophreniaChild and Adolescent Psychopharmacology News20011
43Do Families Comply with Child and Adolescent Psychopharmacology?Child and Adolescent Psychopharmacology News20011
44Longitudinal Clinical Course of Early Onset DepressiveDisorders: Treatment ImplicationsChild and Adolescent Psychopharmacology News20011
45A Double-Edged Sword: Atypical Antipsychotics in Child and Adolescent PsychiatryChild and Adolescent Psychopharmacology News20031
46Drug-Induced QT Interval Prolongation and Torsade De Pointes in Children and Adolescents—Part II of a Four Part SeriesChild and Adolescent Psychopharmacology News20031
47Drug-Induced QT Interval Prolongation and Torsade De Pointes in Children and Adolescents—Part III of a Four Part SeriesChild and Adolescent Psychopharmacology News20031
48Drug-Induced QT Interval Prolongation and Torsade De Pointes in Children and Adolescents—Part IV of a Four Part SeriesChild and Adolescent Psychopharmacology News20031
49The Hand-to-Hand Family Education Program: A Means of Reducing Parental Stress and Increasing Support in Families of Children with Brain DisordersChild and Adolescent Psychopharmacology News20041
50Long-Term Stimulant Effects in Children with Attention Deficit Hyperactivity Disorder (ADHD)Child and Adolescent Psychopharmacology News20041